TR199902383T2 - Yeni pirimidin t�revleri ve bunlar�n haz�rlanmas� i�in proses. - Google Patents

Yeni pirimidin t�revleri ve bunlar�n haz�rlanmas� i�in proses.

Info

Publication number
TR199902383T2
TR199902383T2 TR1999/02383T TR9902383T TR199902383T2 TR 199902383 T2 TR199902383 T2 TR 199902383T2 TR 1999/02383 T TR1999/02383 T TR 1999/02383T TR 9902383 T TR9902383 T TR 9902383T TR 199902383 T2 TR199902383 T2 TR 199902383T2
Authority
TR
Turkey
Prior art keywords
pyrimidine derivatives
preparation
new pyrimidine
new
intermediates
Prior art date
Application number
TR1999/02383T
Other languages
English (en)
Turkish (tr)
Inventor
Wook Lee Jong
Yong Lee Bong
Seop Kim Chang
Kyu Lee Seung
Seog Song Keun
Jin Lee Song
Jeon Shim Woo
Soon Hwang Man
Original Assignee
Yuhan Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corporation filed Critical Yuhan Corporation
Publication of TR199902383T2 publication Critical patent/TR199902383T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TR1999/02383T 1997-03-27 1998-03-24 Yeni pirimidin t�revleri ve bunlar�n haz�rlanmas� i�in proses. TR199902383T2 (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR19970010863 1997-03-27
KR19970010862 1997-03-27
PCT/KR1998/000058 WO1998043968A1 (en) 1997-03-27 1998-03-24 Novel pyrimidine derivatives and processes for the preparation thereof

Publications (1)

Publication Number Publication Date
TR199902383T2 true TR199902383T2 (xx) 2000-06-21

Family

ID=26632616

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02383T TR199902383T2 (xx) 1997-03-27 1998-03-24 Yeni pirimidin t�revleri ve bunlar�n haz�rlanmas� i�in proses.

Country Status (21)

Country Link
US (1) US6352993B1 (OSRAM)
EP (1) EP1015444B1 (OSRAM)
JP (1) JP3176379B2 (OSRAM)
KR (1) KR100278857B1 (OSRAM)
CN (1) CN1118464C (OSRAM)
AR (1) AR012181A1 (OSRAM)
AT (1) ATE241613T1 (OSRAM)
AU (1) AU720385B2 (OSRAM)
BR (1) BR9808070A (OSRAM)
CA (1) CA2284795C (OSRAM)
DE (1) DE69815126T2 (OSRAM)
DK (1) DK1015444T3 (OSRAM)
ES (1) ES2200324T3 (OSRAM)
HU (1) HUP0000851A3 (OSRAM)
IN (1) IN188411B (OSRAM)
PT (1) PT1015444E (OSRAM)
RU (1) RU2203894C2 (OSRAM)
TR (1) TR199902383T2 (OSRAM)
TW (1) TW542831B (OSRAM)
UY (1) UY24938A1 (OSRAM)
WO (1) WO1998043968A1 (OSRAM)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100272471B1 (ko) 1998-11-17 2000-11-15 김선진 신규의 피리미딘 유도체 및 그의 제조방법
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
AR038368A1 (es) 2002-02-01 2005-01-12 Novartis Ag Compuestos n-pirimidin-2-il-aminas sustituidas como inhibidores de ige, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de un medicamento
US7211590B2 (en) 2002-08-01 2007-05-01 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
CA2533397A1 (en) * 2003-07-22 2005-02-03 Neurogen Corporation Substituted pyridin-2-ylamine analogues
EP1678168B1 (en) * 2003-10-24 2012-07-11 Exelixis, Inc. P70s6 kinase modulators and method of use
CA2544325A1 (en) 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
KR101122376B1 (ko) * 2005-03-09 2012-03-26 주식회사유한양행 신규의 5,6-다이메틸피리미딘 유도체 및 그의 제조방법
JP2009511548A (ja) * 2005-10-14 2009-03-19 ノイロサーチ アクティーゼルスカブ 新規ピリミジン−２，４−ジアミン誘導体及び小コンダクタンスのカルシウム依存性カリウムチャネルのモジュレーターとしてのこれらの使用
JP4946482B2 (ja) 2007-02-08 2012-06-06 船井電機株式会社 緩衝用梱包材及びｔｖ受像機の緩衝用梱包材
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
AU2009278442B2 (en) 2008-08-05 2013-09-26 Daiichi Sankyo Company, Limited Imidazopyridin-2-one Derivatives
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
EP2640705A2 (en) 2010-11-15 2013-09-25 Katholieke Universiteit Leuven Novel antiviral compounds
US9890138B2 (en) 2011-02-25 2018-02-13 Yuhan Corporation Diaminopyrimidine derivatives and processes for the preparation thereof
US9447051B2 (en) * 2012-02-17 2016-09-20 Abbvie Inc. Diaminopyrimidines and uses thereof
IN2014MN02314A (OSRAM) 2012-05-29 2015-08-07 Momentive Performance Mat Inc
PT2922828T (pt) 2012-11-21 2020-10-12 Ptc Therapeutics Inc 4,6-diamino-pirimidina derivados como inibidores de bmi-1 para tratamento do cancro
RU2015143517A (ru) 2013-03-13 2017-04-19 Дженентек, Инк. Пиразолсодержащие соединения и их применения
CA2922657C (en) 2013-08-30 2022-04-12 Ptc Therapeutics, Inc. Substituted pyrimidine bmi-1 inhibitors
EP3055301B1 (en) * 2013-10-07 2019-11-20 Kadmon Corporation, LLC (2-(5-isoindolin-2-yl)pyrimidin-4-yl)-amine derivatives as rho kinase inhibitors for treating autoimmune diseases
EP3071553A4 (en) 2013-11-21 2017-08-02 PTC Therapeutics, Inc. Substituted pyridine and pyrazine bmi-1 inhibitors
AU2015335980A1 (en) * 2014-10-22 2017-05-18 Guangzhou Institutes Of Biomedicine And Health, Chinese Academy Of Sciences Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof
CN105669642B (zh) * 2014-11-19 2020-06-09 江苏天士力帝益药业有限公司 一种盐酸洛氟普啶的制备方法
ES2915948T3 (es) * 2016-01-04 2022-06-27 ObsEva SA Administración conjunta de alfa-aminoéster de derivado de hidroxipropiltiazolidin-carboxamida y un agente tocolítico
CN110461833A (zh) * 2017-04-05 2019-11-15 拜耳作物科学股份公司 2-氨基-5-氧基烷基嘧啶衍生物及其用于防治不希望的植物生长的用途
BR112021002630A2 (pt) 2018-08-17 2021-05-11 Ptc Therapeutics, Inc. método para tratar câncer pancreático
CN114685369B (zh) * 2022-05-17 2024-02-02 河南省科学院高新技术研究中心 一种利用离子液体制备1-甲基-1,2,3,4-四氢异喹啉的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980781A (en) 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
GB1182584A (en) 1966-03-31 1970-02-25 Ici Ltd Pyrimidine derivates and the use thereof as fungicides
US4000138A (en) 1966-03-31 1976-12-28 Imperial Chemical Industries Limited Organic compounds and compositions containing them
GB1383409A (en) 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
US4044136A (en) 1972-09-09 1977-08-23 Pfizer Inc. Aminoquinazoline therapeutic agents
US3956495A (en) 1973-10-30 1976-05-11 Eli Lilly And Company 2,4-Diaminoquinazolines as antithrombotic agents
US4755218A (en) 1985-12-31 1988-07-05 Monsanto Company Haloacyl 1-substituted-1,2,3,4-tetrahydro-isoquinolines as herbicide antidotes
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
IL88507A (en) * 1987-12-03 1993-02-21 Smithkline Beckman Intercredit 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them
US4966622A (en) 1988-04-12 1990-10-30 Ciba-Geigy Corporation N-phenyl-N-pyrimidin-2-ylureas
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
DE3901448A1 (de) 1989-01-19 1990-07-26 Basf Ag Emulsionscopolymerisate
DK0388838T3 (da) 1989-03-22 1996-02-05 Ciba Geigy Ag Parasiticid
CA2015981A1 (en) * 1989-05-10 1990-11-10 Thomas H. Brown Compounds
GB8910722D0 (en) 1989-05-10 1989-06-28 Smithkline Beckman Intercredit Compounds
GB9012592D0 (en) 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds
JPH05507290A (ja) 1990-11-06 1993-10-21 フアイザー・インコーポレイテツド 抗腫瘍活性を強化するためのキナゾリン誘導体
AU653601B2 (en) * 1991-04-17 1994-10-06 Pfizer Inc. Pyrimidine derivatives for enhancing antitumor activity
US5276186A (en) 1992-03-11 1994-01-04 Ciba-Geigy Corporation Process for the production of guanidine derivatives
KR0144833B1 (ko) * 1992-12-28 1998-07-15 김태훈 신규의 퀴나졸린 유도체 및 그의 제조방법
JPH09501918A (ja) * 1993-08-12 1997-02-25 アストラ・アクチエボラーグ 酸化窒素合成酵素活性を有するアミジン誘導体
EP0640599B1 (en) 1993-08-26 1998-03-04 Ono Pharmaceutical Co., Ltd. 4-Aminopyrimidine derivatives
WO1995010506A1 (en) 1993-10-12 1995-04-20 The Du Pont Merck Pharmaceutical Company 1n-alkyl-n-arylpyrimidinamines and derivatives thereof
US5750531A (en) * 1994-08-13 1998-05-12 Yuhan Corporation Pyrimidine derivatives and processes for the preparation thereof
EP0900214B1 (en) * 1996-05-04 2001-09-26 Yuhan Corporation Process for preparation of pyrimidine derivatives

Also Published As

Publication number Publication date
RU2203894C2 (ru) 2003-05-10
JP2000513014A (ja) 2000-10-03
ES2200324T3 (es) 2004-03-01
BR9808070A (pt) 2000-03-08
EP1015444A1 (en) 2000-07-05
DE69815126D1 (de) 2003-07-03
HUP0000851A3 (en) 2002-04-29
CN1118464C (zh) 2003-08-20
TW542831B (en) 2003-07-21
US6352993B1 (en) 2002-03-05
PT1015444E (pt) 2003-10-31
AR012181A1 (es) 2000-09-27
HUP0000851A1 (hu) 2001-04-28
CA2284795A1 (en) 1998-10-08
DK1015444T3 (da) 2003-08-18
ATE241613T1 (de) 2003-06-15
CA2284795C (en) 2004-01-20
WO1998043968A1 (en) 1998-10-08
IN188411B (OSRAM) 2002-09-21
JP3176379B2 (ja) 2001-06-18
HK1026418A1 (en) 2000-12-15
KR19980080789A (ko) 1998-11-25
DE69815126T2 (de) 2004-04-08
AU720385B2 (en) 2000-06-01
CN1251586A (zh) 2000-04-26
EP1015444B1 (en) 2003-05-28
AU6523998A (en) 1998-10-22
UY24938A1 (es) 2001-01-31
KR100278857B1 (ko) 2001-01-15

Similar Documents

Publication Publication Date Title
TR199902383T2 (xx) Yeni pirimidin t�revleri ve bunlar�n haz�rlanmas� i�in proses.
TR200101764T2 (tr) Yeni bileşikler.
TR200103428T2 (tr) IMPDH enzim inhibitörleri.
TR199902082T2 (xx) Pirazin bile�ikleri.
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
TR200102800T2 (tr) Yeni bileşikler.
IL124411A0 (en) Lipopolyamines as transfection agents and pharmaceutical uses thereof
TR200101412T2 (tr) Yeni bileşikler.
TR199901408T2 (xx) Yak�t gaz� i�ermeyen aeresollerin �retimine mahsus ila� bile�imleri.
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
TR199802344A2 (xx) �kame edilmi� imidazolidin t�revleri
TR199800436A2 (xx) Primidin t�revlerinin kanserin �nlenmesi i�in kullan�lmas�.
TR200001645T2 (tr) Retinoyik asit taklidi anilürler.
DE69931925D1 (de) 2-chinolonen enthaltende arzneimittel
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
BR0008228A (pt) Composições de n-benzoil estaurosporinaespontaneamente dispersìveis
TR200400187T2 (tr) Yeni oral formülasyon.
IT1299583B1 (it) Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
TR199700261A2 (xx) Yeni Pirimido (1,2-a) indoller.
UY26426A1 (es) Nuevos compuestos
ATE277010T1 (de) Bis-indolederivate und ihre verwendung als entzündungshemmende mittel
TR200002461T2 (tr) Streptogramin türevleri, hazırlanışları ve bunları içeren bileşimler.
SE9803272D0 (sv) A drug for cell regeneration
IL134930A0 (en) Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing the same
FI853228A7 (fi) Uudet -butyrolaktaamit, niiden farmaseuttisesti aktiiviset koostumukset, menetelmät niiden valmistamiseksi ja niiden käyttö lääkeaineina.